.jpg?format=webp&width=780)
The study aimed to evaluate the effectiveness and safety of hydroxychloroquine (HCQ) prophylaxis for preventing SARS-CoV-2 infection in healthcare workers (HCW) during the COVID-19 pandemic. The study randomly allocated 68 HCWs to receive HCQ or not. The results showed no significant difference in the incidence of SARS-CoV-2 infections between both study arms, and there were no serious adverse events. However, poor participant accrual led to low statistical power, and two participants withdrew consent due to adverse events.
Like
Save
Share